Literature DB >> 1462661

Chagas disease: epidemiology and prospects for interruption of transmission in the Americas.

A Moncayo1.   

Abstract

American trypanosomiasis, or Chagas disease, is a parasitic disease caused by the haemoflagellate protozoa, Trypanosoma cruzi. The human infection occurs only in the Americas, where it is widely distributed in the periurban and rural areas of tropical and subtropical countries, from Mexico to Argentina and Chile. It is transmitted to man and other mammals mainly through insects, the triatomine bugs. As an enzootic disease, it extends from approximately latitude 42.5 degrees N (northern California and Maryland) to latitude 43.5 degrees S (southern Argentina and Chile). The results of several serological surveys indicate an overall prevalence of 16-18 million infected individuals. Up to 30% of those infected will develop the cardiac and/or hollow viscera irreversible lesions that characterize chronic Chagas disease. The endemic countries can be divided into four groups according to several indicators such as the number of confirmed human cases, the prevalence of seropositive tests in blood donors and population samples, the presence of infected vectors and reservoirs, and the existence or absence of coordinated actions towards the control of this disease. The domestic cycle of transmission, involving man and domestic animals such as dogs, cats, and domestic triatomine bugs, is the one that maintains the infections in the rural and periurban areas. Some triatomine species are well adapted to human dwellings where human and animal reservoirs are in intimate contact. The poor socioeconomic condition of the population and the domestic nature of the vector play crucial roles in maintaining the infection at an endemic level.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1462661

Source DB:  PubMed          Journal:  World Health Stat Q        ISSN: 0379-8070


  13 in total

1.  Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment.

Authors:  Vera Lucia Pereira-Chioccola; Abilio Augusto Fragata-Filho; Antonio Marcos de Apparecida Levy; Mauricio M Rodrigues; Sergio Schenkman
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

2.  Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways.

Authors:  Nisha Garg; Arpad Gerstner; Vandanajay Bhatia; James DeFord; John Papaconstantinou
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

3.  Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes.

Authors:  N Garg; M Postan; K Mensa-Wilmot; R L Tarleton
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.

Authors:  B Wizel; N Garg; R L Tarleton
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

5.  The impact of climate change on the geographical distribution of two vectors of Chagas disease: implications for the force of infection.

Authors:  Paula Medone; Soledad Ceccarelli; Paul E Parham; Andreína Figuera; Jorge E Rabinovich
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-04-05       Impact factor: 6.237

6.  Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides.

Authors:  A W Ferreira; Z R Belem; E A Lemos; S G Reed; A Campos-Neto
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens.

Authors:  J M Peralta; M G Teixeira; W G Shreffler; J B Pereira; J M Burns; P R Sleath; S G Reed
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Isolation of Beauveria bassiana (Bals.) Vuill. (Deuteromycotina: Hyphomycetes) from the Chagas disease vector, Triatoma infestans (Hemiptera: Reduviidae) in Argentina.

Authors:  G A Marti; A C Scorsetti; A Siri; C C López Lastra
Journal:  Mycopathologia       Date:  2005-04       Impact factor: 2.574

9.  Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.

Authors:  B Wizel; M Palmieri; C Mendoza; B Arana; J Sidney; A Sette; R Tarleton
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

10.  Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.

Authors:  Nisha Garg; Rick L Tarleton
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.